The global autoinjector market reached a value of US$ 1.65 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.39 Billion by 2027, exhibiting a CAGR of 16.70% during 2022-2027.
Autoinjectors refer to self-injectable medical devices used to administer drugs and antidotes through the subcutaneous or intramuscular route. They comprise spring-loaded prefilled syringes or cartridges that deliver a calculated dose of medication upon being activated. They facilitate easy self-administration, enhance patient compliance, lower anxiety, and ensure dosage accuracy. They also help reduce needle phobia of patients, minimize needlestick injuries caused by hidden needles, and improve the efficiency of healthcare professionals. As a result, autoinjectors are widely utilized for rapid and safe drug administration during emergency conditions, including diabetes, multiple sclerosis (MS), migraine, seizures, psoriasis, and rheumatoid arthritis.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/autoinjector-market/requestsample
|Base Year: 2021|
|Forecast Year: 2022-2027|
Autoinjector Market Trends and Drivers:
The global autoinjector market is primarily driven by the increasing incidences of chronic and lifestyle diseases and the escalating demand for enhanced patient convenience. Additionally, individuals are rapidly shifting from conventional devices toward self-administrating devices, such as autoinjectors, due to the growing awareness regarding their benefits.
In line with this, several favorable initiatives undertaken by governments of various countries to promote the usage of autoinjectors in schools for first-aid treatment during emergencies have augmented the product demand. Furthermore, the leading players are launching innovative, simple, and cost-effective autoinjectors based on advanced technologies for treating relapsing-remitting MS and other conditions, thereby propelling the market growth.
Other factors, including the expanding healthcare industry, aging population, rising product approvals, surging adoption of targeted therapies, growing inclination toward homecare therapeutics, and ongoing research and development (R&D) activities, are also anticipated to drive the market further.
Global Autoinjector Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Amgen Inc., Antares Pharma Inc., Becton Dickinson and Company, Bristol-Myers Squibb Company, Eisai Co. Ltd., Eli Lilly and Company, Haselmeier GmbH (Sulzer Ltd.), Johnson & Johnson, Mylan N.V. (Viatris Inc.), Novartis AG, SHL Medical AG, Teva Pharmaceutical Industries Ltd. and Ypsomed Holding AG.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://bit.ly/3rLHIXb
The report has segmented the market on the basis of region, type, application and end user.
Breakup by Type:
- Disposable Autoinjectors
- Reusable Autoinjectors
Breakup by Application:
- Rheumatoid Arthritis
- Multiple Sclerosis
Breakup by End User:
- Home Care Settings
- Hospitals and Clinics
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5436&flag=F
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited. 30 N Gould St Ste R Sheridan, WY 82801 USA – Wyoming Email: [email protected] Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800